Activities of José Inácio FARIA related to 2017/2254(INI)
Plenary speeches (1)
A European One Health Action Plan against Antimicrobial Resistance (debate) PT
Amendments (34)
Amendment 8 #
Motion for a resolution
Citation 14 a (new)
Citation 14 a (new)
– having regard to the Seventieth World Health Assembly, Resolution on improving the prevention, diagnosis and clinical management of sepsis of 29 May 2017;
Amendment 43 #
Motion for a resolution
Recital C
Recital C
C. whereas healthcare-associated infections (HAI) are often duedue to lacking prevention measures often leading to antibiotic-resistant bacteria; whereas the European Centre for Disease Prevention and Control (ECDC) estimates that approximately 4 million patients acquire a HAI each year in the EU and that approximately 37 000 deaths result directly from these infections; whereas at least 20% of HAI are estimated to be preventable by sustained and multifaceted infection prevention and control programmes;
Amendment 65 #
Motion for a resolution
Recital E a (new)
Recital E a (new)
Ea. whereas the World Health Assembly estimates that sepsis – as a death-leading syndromic response to most infectious diseases – causes approximately 6 million deaths worldwide every year, which are mostly preventable.
Amendment 92 #
Motion for a resolution
Paragraph 1 a (new)
Paragraph 1 a (new)
1a. Recalls that continuously updated information on the real burden of AMR is necessary; emphasizes the magnitude of the problem will also underline the clear European-added value of the European One Health Action Plan against AMR;
Amendment 106 #
Motion for a resolution
Paragraph 2
Paragraph 2
2. Stresses that the appropriate and prudentresponsible use of antimicrobials is essential to limiting the emergence of AMR in human healthcare, animal husbandry and aquaculture; stresses that there are considerable differences in the way Member States handle and address AMR; calls on the Commission to consider mandatory routine collection and submission of monitoring data in all One Health domains at EU level and to establish indicators to measure progress in the fight against AMR;
Amendment 139 #
Motion for a resolution
Paragraph 3
Paragraph 3
3. Calls on the Commission and the Member States to align surveillance, monitoring and reporting of AMR patterns and pathogens by establishing indicators that measure and compare progress in the fight against AMR and to encourage the evaluation of the standardized data;
Amendment 145 #
Motion for a resolution
Paragraph 3 a (new)
Paragraph 3 a (new)
3a. Stresses the need for a time frame embedding the European One Health Action Plan; calls on the Commission and the Member States to include measurable, time-bound objectives in both the European One Health Action Plan and in national action plans to enable benchmarking;
Amendment 146 #
Motion for a resolution
Paragraph 3 b (new)
Paragraph 3 b (new)
3b. Calls on the Commission to coordinate and monitor national strategies to enable sharing of best practices between Member States;
Amendment 147 #
Motion for a resolution
Paragraph 3 c (new)
Paragraph 3 c (new)
3c. Calls on the Commission to conduct and publish a mid-term evaluation and ex-post evaluation of the One Health Action Plan and to involve all relevant stakeholders in the evaluation procedure;
Amendment 160 #
Motion for a resolution
Paragraph 5
Paragraph 5
5. Urges the Commission to expand the role and funding of the ECDC in the fight against AMR and HAI;
Amendment 165 #
Motion for a resolution
Paragraph 6
Paragraph 6
6. Emphasises that infection prevention, biosecurity measures and control practices are critical in the control of all infectious microorganisms as they reduce the need for antimicrobials and consequently opportunities for microorganisms to develop and spread resistance; stresses the need for mandatory reporting to public health authorities of all patients who are found to be infected or identified as carriers of highly resistant bacteria; stresses the need for guidelines on isolation of hospitalised carriers and the creation of a multidisciplinary professional taskforce reporting directly to the Ministry of Health;
Amendment 174 #
Motion for a resolution
Paragraph 6 a (new)
Paragraph 6 a (new)
6a. Encourages the focus on compliance to infection control guidelines, integrating targets for infection rate reductions, supporting good practice to help address patient safety in the hospital environment;
Amendment 179 #
Motion for a resolution
Paragraph 7
Paragraph 7
7. Calls on the Commission and the Member States to develop public health messages to raise public awareness and in doing so promote a change in behaviour towards the responsible use of antibiotics; underlines the importance of promoting ‘health literacy’, since it is crucial that patients understand healthcare information and are able to follow treatment instructions accurately; stresses that preventive measures, including hygiene, should be scaled up to reduce the amount of antibiotics currently required to treat infections and for medical procedures; stresses that awareness on the perils of self-medication and over-prescription should be a core component of a preventive strategy, and de-prescription by healthcare professionals a possible solution;
Amendment 197 #
Motion for a resolution
Paragraph 8
Paragraph 8
8. Urges the Commission and Member States to create harmonised quality standards in EU-wide curricula and proper stewardship for health professionals in relation to prescribing, dosage, use and disposal of antimicrobials, and to ensure the establishment and deployment of multidisciplinary antibiotic stewardship teams in hospital settings;
Amendment 205 #
Motion for a resolution
Paragraph 9
Paragraph 9
9. Is aware that health professionals often need to make quick decisions on therapeutic indication for antibiotic treatment; notes that rapid diagnostic tests can help to support theseffective and accurate decisions-making;
Amendment 226 #
Motion for a resolution
Paragraph 11
Paragraph 11
11. Calls on the Commission and the Member States to restrict or stop the sale of antibiotics by those doctors or veterinarianhuman and animal health professionals who also prescribe them, and to remove any incentives for the prescription of antibiotics;
Amendment 253 #
Motion for a resolution
Paragraph 12
Paragraph 12
12. Highlights the value of vaccines in combating AMR; recommends integration of targets for life-long vaccination in the population, particularly in vulnerable groups, as a key element of national action plans on AMR;
Amendment 262 #
Motion for a resolution
Paragraph 12 a (new)
Paragraph 12 a (new)
12 a. Calls Member States to strengthen efforts to prevent and control infections that can lead to sepsis; calls Member States to include in their national AMR action plans targeted measures to improve the prevention, early identification and diagnosis and clinical management of sepsis;
Amendment 271 #
Motion for a resolution
Paragraph 13
Paragraph 13
13. Highlights that the pollution of the environment by human and veterinary antibiotic residues is an emerging problem andthat requires coherent policy measures to avoid the spreading of AMR between ecosystems, animals and people; encourages further research into transmission dynamics and the relative impact of this pollution on AMR;
Amendment 291 #
Motion for a resolution
Paragraph 14
Paragraph 14
14. Calls for environmental risk assessments as part of the marketing authorisation process for antimicrobials as well as for older products already on the market;
Amendment 301 #
Motion for a resolution
Paragraph 14 a (new)
Paragraph 14 a (new)
14 a. Calls for the strict abiding of Good Manufacturing Practices and green procurement rules regarding the production and distribution of pharmaceuticals in and into the EU;
Amendment 307 #
Motion for a resolution
Paragraph 14 b (new)
Paragraph 14 b (new)
14 b. Urges the Commission to formally include civil society in One Health discussions, for example by setting up and funding a dedicated stakeholder network;
Amendment 309 #
Motion for a resolution
Paragraph 14 c (new)
Paragraph 14 c (new)
14 c. Stresses that not all Member States possess sufficient resources to develop and implement comprehensive national AMR strategies; urges the Commission to provide Member States with clear information about available EU sources to tackle AMR and to make available more dedicated funding for this purpose;
Amendment 314 #
Motion for a resolution
Paragraph 14 d (new)
Paragraph 14 d (new)
14 d. Urges the Commission to effectively deploy available legislation in all AMR-related areas to ensure that the threat is being tackled in all policies;
Amendment 315 #
Motion for a resolution
Paragraph 14 e (new)
Paragraph 14 e (new)
14 e. Underlines the importanceof a life cycle assessment approach, from production and prescription to the management of pharmaceutical waste; asks the Commission to address the disposal of antibiotics issue where alternatives to incineration should be explored, such as gasification;
Amendment 342 #
Motion for a resolution
Paragraph 18
Paragraph 18
18. Calls on the Commission to increase funding for early research in epidemiology and immunology of AMR pathogens, in particular the pathways of transmission between animals and humans and the environment, as well as the health associated infections (HAI);
Amendment 349 #
Motion for a resolution
Paragraph 18 a (new)
Paragraph 18 a (new)
18 a. Welcomes recent cross-border research projects into antimicrobial stewardship and the prevention of infection;
Amendment 365 #
Motion for a resolution
Paragraph 21
Paragraph 21
21. Calls on the Commission and the Member States to support the implementation of new economic models, pilot projects and incentives to boost the development of new diagnostics, antibiotics, alternatives to using antimicrobials, medical devices, and vaccines;
Amendment 370 #
Motion for a resolution
Paragraph 21 a (new)
Paragraph 21 a (new)
21 a. Encourages the uptake of cost- effectiveness technologies that reduce the impact of health associated infections (HAIs) in hospitals and help preventing the spread of multi-resistant microorganisms;
Amendment 404 #
Motion for a resolution
Paragraph 24
Paragraph 24
24. Recalls that owing to the complexity of the problem, its cross-border dimension, the severe consequences for environment, human and animal health and the high economic burden, AMR requires urgent and coordinated global and intersectoral action;
Amendment 410 #
Motion for a resolution
Paragraph 25
Paragraph 25
25. Welcomes the WHO Global Action Plan (GAP) on AMR, which was adopted unanimously in May 2015 by the 68th World Health Assembly; stresses the need for global, European and national action plans to be aligned;
Amendment 439 #
Motion for a resolution
Paragraph 28
Paragraph 28
28. Calls on the Commission and the Member States to strengthen measures to combat illegal practices related to the trade and use of antimicrobialmanufacture, trade, use and disposal of antimicrobials; emphasizes that actors involved in the life-cycle chain of antimicrobials are to take responsibility for their actions;
Amendment 446 #
Motion for a resolution
Paragraph 29
Paragraph 29
29. Calls on the Commission to work towards continued high-level political attention and commitment to AMR action, including in UN forums, the G7 and the G20; highlights the opportunity for European scientific bodies, like ECDC, to take global stewardship roles;
Amendment 450 #
Motion for a resolution
Paragraph 29 a (new)
Paragraph 29 a (new)
29 a. Calls on the Commission to advocate collaboration between the EU and international organisations, including WHO, FAO, and OIE;